43799 Efficacy and Safety of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Study
Alexa B. Kimball, Lindsay Ackerman, Bethanee J. Schlosser, Vimal H. Prajapati, Scott Fretzin, Hidetoshi Takahashi, Tianyu Zhan, Xiaohong Huang, Heidi S. Camp
Topics & Concepts
Hidradenitis suppurativaMedicinePlaceboDermatologyRandomized controlled trialSurgeryInternal medicineAlternative medicinePathologyDiseaseHidradenitis Suppurativa and TreatmentsChemotherapy-related skin toxicityColorectal and Anal Carcinomas